Opnurasib,2653994-08-0

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Opnurasib

CAS No. : 2653994-08-0

MCE 国际站：Opnurasib

产品活性：Opnurasib (JDQ-443) (NVP-JDQ443) 是一种口服有效和选择性的共价 KRAS G12C 抑制剂。Opnurasib 具有抗肿瘤活性。

研究领域：GPCR/G Protein  |  Cell Cycle/DNA Damage

作用靶点：Ras  |  PERK

In Vitro: Opnurasib (NVP-JDQ443) traps the GDP-bound inactive conformation of KRAS.
?Opnurasib promotes dose-dependent reductions of phosphorylated ERK (pERK) levels and the proliferation of the KRASG12C-mutated cell lines NCI-H358 and NCI-H2122, with IC₅₀ values of 0.018 and 0.063 μM, respectively.
?Opnurasib covalently and selectively binds and inhibits GDP-bound KRASG12C with low reversible binding affinity to the RAS switch II pocket, and also inhibits proliferation of KRASG12C-mutated and KRAS G12C/H95, G12C/R68S, and G12C/Y96 double-mutant cell lines.

In Vivo: Opnurasib (10-100 mg/kg, Orally, daily for 14 days) shows antitumor activity in KRAS G12C-mutated CDX models.
?Opnurasib (Orally, 100 mg/kg, daily (JDQ443) + 7.5 mg/kg, twice daily (TNO155), for 36 days) shows greater cell growth inhibition or cell killing compared with single-agent JDQ443 when combined with TNO155.
?Opnurasib generates categorical antitumor responses in PDX models of NSCLC and colorectal tumors that are improved by combination treatment with other agents.

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Cell Cycle/DNA Damage Compound Library  |  GPCR/G Protein Compound Library  |  Kinase Inhibitor Library  |  Anti-Cancer Compound Library  |  Clinical Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Ferroptosis Compound Library  |  Endoplasmic Reticulum Stress Compound Library  |  Orally Active Compound Library  |  Glutamine Metabolism Compound Library  |  Anti-Lung Cancer Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Anti-Blood Cancer Compound Library  |  Angiogenesis-Related Compound Library  |  Anti-Liver Cancer Compound Library   |  Anti-Colorectal Cancer Compound Library   |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Inhibitors Library  |  Sotorasib  |  MRTX1133  |  Adagrasib  |  GSK2606414  |  ISRIB (trans-isomer)  |  BI-2852  |  BI-3406  |  GSK2656157  |  Ketoconazole  |  NSC 23766 trihydrochloride  |  BI-2865  |  CCT020312  |  ML141  |  BAY-293  |  CID-1067700  |  Rhosin hydrochloride  |  AMG PERK 44  |  Lonafarnib  |  EHT 1864  |  GGTI298 Trifluoroacetate  |  MBQ-167  |  MRTX0902  |  Divarasib  |  ARS-1620  |  CCG-1423  |  CASIN  |  Salirasib  |  EHop-016  |  MK-28

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds